Publications by authors named "Ugo Randazzo"

Claim this Profile
-
-mutated endometrial cancer: new perspectives on the horizon?
Daniele Fanale, Lidia Rita Corsini, Paola Piraino, Erika Pedone, Chiara Brando, Ugo Randazzo

Front Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Scientific Communication and oncology - "The bridge between knowledge and patients".
Antonio Galvano, Andrea Gottardo, Valerio Gristina, Daniele Fanale, Lidia Rita Corsini, Ugo Randazzo

Crit Rev Oncol Hematol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polθ: emerging synthetic lethal partner in homologous recombination-deficient tumors.
Tancredi Didier Bazan Russo, Clarissa Mujacic, Emilia Di Giovanni, Maria Concetta Vitale, Carla Ferrante Bannera, Ugo Randazzo

Cancer Gene Ther· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
-
-associated hereditary male cancers: can gender affect the prevalence and spectrum of germline pathogenic variants?
Daniele Fanale, Lidia Rita Corsini, Chiara Brando, Ugo Randazzo, Marco Bono

Front Oncol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Roles of Tumor-Educated Platelets (TEPs) in the biology of Non-Small Cell Lung Cancer (NSCLC): A systematic review. "Re-discovering the neglected biosources of the liquid biopsy family".
Andrea Gottardo, Valerio Gristina, Alessandro Perez, Emilia Di Giovanni, Silvia Contino, Ugo Randazzo

J Liq Biopsy· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical relevance of exosome-derived microRNAs in Ovarian Cancer: Looking for new tumor biological fingerprints.
Daniele Fanale, Lidia Rita Corsini, Marco Bono, Ugo Randazzo, Nadia Barraco

Crit Rev Oncol Hematol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential agnostic role of BRCA alterations in patients with several solid tumors: One for all, all for one?
Daniele Fanale, Lidia Rita Corsini, Erika Pedone, Ugo Randazzo, Alessia Fiorino

Crit Rev Oncol Hematol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low plasma PD-L1 levels, early tumor onset and absence of peritoneal carcinomatosis improve prognosis of women with advanced high-grade serous ovarian cancer.
Daniele Fanale, Chiara Brando, Lidia Rita Corsini, Sofia Cutaia, Mariano Catello Di Donna, Ugo Randazzo

BMC Cancer· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic and Predictive Role of Tumor-Infiltrating Lymphocytes (TILs) in Ovarian Cancer.
Daniele Fanale, Alessandra Dimino, Erika Pedone, Chiara Brando, Lidia Rita Corsini, Ugo Randazzo

Cancers (Basel)· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can circulating PD-1, PD-L1, BTN3A1, pan-BTN3As, BTN2A1 and BTLA levels enhance prognostic power of CA125 in patients with advanced high-grade serous ovarian cancer?
Daniele Fanale, Lidia Rita Corsini, Chiara Brando, Sofia Cutaia, Mariano Catello Di Donna, Ugo Randazzo

Front Oncol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MUTYH-associated tumor syndrome: The other face of MAP.
Luigi Magrin, Daniele Fanale, Chiara Brando, Lidia Rita Corsini, Ugo Randazzo

Oncogene· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis